Friday, December 19, 2025

LATEST NEWS

PHARMA

Medtech

Real Estate

People on the Move

Suffolk hires Roger Moore to strengthen healthcare construction leadership in California

Life Sciences Times - 0
SAN FRANCISCO — Suffolk has appointed construction management executive Roger Moore as a Vice President and Project Executive in its San Francisco office, reinforcing...

Curium Pharma Selects Boston Seaport for New Global Headquarters

Instem Opens New Global Headquarters in Boston

Life Sciences

Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells

Life Sciences Times - 0
MADISON, Wis. — A study published in Nature Communications reports new findings on how cancer cells respond to targeted drugs, identifying a direct connection...

Entrepreneur of the Year Award Honors Dermatology Innovator Reid Waldman, M.D.

Life Sciences Times - 0
NEW HAVEN, Conn. — BioCT and Shipman & Goodwin LLP announced that Reid Waldman, M.D., chief executive officer of Veradermics, has been named Entrepreneur...

Life Sciences and Investment Leaders at BioFuture 2025 Signal Renewed Optimism in Health and Biotech Sectors

Life Sciences Times - 0
NEW YORK — Demy-Colton’s BioFuture 2025 conference concluded in New York and virtually this week, highlighting renewed confidence in the biotech sector and the...

ONDEX Automation Acquires PlantOPS Consulting to Expand Life Sciences Capabilities

Life Sciences Times - 0
CHICAGO — ONDEX Automation has acquired PlantOPS Consulting, a provider of Manufacturing Execution System (MES) implementation and consulting services for pharmaceutical, biotechnology, and medical...

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire the Gut’s Nervous System

Life Sciences Times - 0
CAMBRIDGE, Mass. — A landmark study published in Science by researchers at the Broad Institute of MIT and Harvard, in collaboration with the Food...

Today's Headlines

Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders

Life Sciences Times - 0
Venture Capital
BOSTON — Syremis Therapeutics has launched with $165 million in Series A financing to develop novel medicines for serious mental health conditions, aiming to...
Advertisment

LATEST ARTICLES

123...773Page 1 of 773

Most Popular

Load more

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv